SUBSCRIBE
SUBSCRIBE

bioAffinity Technologies, Inc.

IN THE PRESS
Lone Star Bio
bioAffinity Technologies Presents Proprietary Cancer Therapeutic Research at Joint ASCB-EMBO Meeting
December 1, 2022
 · 
3 min read
Business
bioAffinity Technologies Reports Third Quarter 2022 Financial Results and Provides Business Update
November 14, 2022
 · 
10 min read
Business
bioAffinity Technologies Announces Sheila Habib, MD and David Hill, MD Join the Company’s Scientific and Medical Advisory Board
November 10, 2022
 · 
5 min read
Business
bioAffinity Technologies to Report Third Quarter 2022 Financial Results
November 8, 2022
 · 
2 min read
Lone Star Bio
bioAffinity Technologies Announces Award of Therapeutic Patents in China, Mexico and Australia
October 25, 2022
 · 
3 min read
Biotech Beach
bioAffinity Technologies Presents Results from Flow Cytometry Analysis of the Lung at CHEST Conference
October 12, 2022
 · 
3 min read
Deals
bioAffinity Technologies Receives Additional $7.7M from Exercise of Warrants, Total Capital from Public Offering Increases to Approximately $15.6M
September 28, 2022
 · 
3 min read
Biotech Beach
bioAffinity Technologies Publishes Peer-Reviewed Results of High-Throughput Flow Cytometry Use for Evaluating Lung Health in PLOS ONE
September 14, 2022
 · 
3 min read
Deals
bioAffinity Technologies, Inc. Announces Closing of $7.8 Million Initial Public Offering
September 6, 2022
 · 
5 min read
Deals
bioAffinity Technologies Announces Pricing of IPO
September 1, 2022
 · 
4 min read
Load More
JOBS